Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic M Walsh

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 4, 2013
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivoIgor Klyubin, Tomas Ondrejcak, Jennifer Hayes, et al.
Brain Communications|October 11, 2024
Patient-derived tau and amyloid-β facilitate long-term depression <i>in vivo</i>: role of tumour necrosis factor-α and the integrated stress responseNeng-Wei Hu, Tomas Ondrejcak, Igor Klyubin, et al.
Neurobiology of Aging|January 26, 2010
Aβ oligomers inhibit synapse remodelling necessary for memory consolidationDarragh B Freir, Rocio Fedriani, Darren Scully, et al.
Annals of Neurology|December 29, 2006
Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomersMatthew Townsend, James P Cleary, Tapan Mehta, et al.
The European Journal of Neuroscience|May 19, 2004
Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivoIgor Klyubin, Dominic M Walsh, William K Cullen, et al.
Experimental Neurology|October 10, 2009
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseHarald Hampel, Yong Shen, Dominic M Walsh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 29, 2010
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrilsBrian O'Nuallain, Darragh B Freir, Andrew J Nicoll, et al.
ACS Chemical Neuroscience|July 28, 2015
Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation SpectroscopyYinghua Guan, Kevin J Cao, Adam Cantlon, et al.
Annals of Neurology|June 7, 2019
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluidTing Yang, Yifan Dang, Beth Ostaszewski, et al.
Nature Neuroscience|December 21, 2004
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive functionJames P Cleary, Dominic M Walsh, Jacki J Hofmeister, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|December 4, 2013
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivoIgor Klyubin, Tomas Ondrejcak, Jennifer Hayes, et al.
Brain Communications|October 11, 2024
Patient-derived tau and amyloid-β facilitate long-term depression <i>in vivo</i>: role of tumour necrosis factor-α and the integrated stress responseNeng-Wei Hu, Tomas Ondrejcak, Igor Klyubin, et al.
Neurobiology of Aging|January 26, 2010
Aβ oligomers inhibit synapse remodelling necessary for memory consolidationDarragh B Freir, Rocio Fedriani, Darren Scully, et al.
Annals of Neurology|December 29, 2006
Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomersMatthew Townsend, James P Cleary, Tapan Mehta, et al.
The European Journal of Neuroscience|May 19, 2004
Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivoIgor Klyubin, Dominic M Walsh, William K Cullen, et al.
Experimental Neurology|October 10, 2009
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseHarald Hampel, Yong Shen, Dominic M Walsh, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 29, 2010
Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrilsBrian O'Nuallain, Darragh B Freir, Andrew J Nicoll, et al.
ACS Chemical Neuroscience|July 28, 2015
Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation SpectroscopyYinghua Guan, Kevin J Cao, Adam Cantlon, et al.
Annals of Neurology|June 7, 2019
Target engagement in an alzheimer trial: Crenezumab lowers amyloid β oligomers in cerebrospinal fluidTing Yang, Yifan Dang, Beth Ostaszewski, et al.
Nature Neuroscience|December 21, 2004
Natural oligomers of the amyloid-beta protein specifically disrupt cognitive functionJames P Cleary, Dominic M Walsh, Jacki J Hofmeister, et al.
Pageof 13